Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection

Abstract The effectiveness of COVID-19 vaccination in children and adolescents with prior SARS-CoV-2 infection remains unclear, particularly for Omicron subvariants. We evaluate vaccine effectiveness against reinfection with Omicron BA.1/BA.2, BA.4/BA.5, XBB, and later subvariants among 5- to 17-yea...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yuqing Lei, Jiajie Chen, Qiong Wu, Ting Zhou, Bingyu Zhang, Michael J. Becich, Yuriy Bisyuk, Saul Blecker, Elizabeth A. Chrischilles, Dimitri A. Christakis, Lindsay G. Cowell, Mollie R. Cummins, Soledad A. Fernandez, Daniel Fort, Sandy L. Gonzalez, Sharon J. Herring, Benjamin D. Horne, Carol Horowitz, Mei Liu, Susan Kim, Parsa Mirhaji, Abu Saleh Mohammad Mosa, Jennifer A. Muszynski, Catharine I. Paules, Alice I. Sato, Hayden T. Schwenk, Soumitra Sengupta, Srinivasan Suresh, Bradley W. Taylor, David A. Williams, Yongqun He, Jeffrey S. Morris, Ravi Jhaveri, Christopher B. Forrest, Yong Chen, On behalf of the RECOVER Consortium
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2026-04-01
Col·lecció:	Nature Communications
Accés en línia:	https://doi.org/10.1038/s41467-026-71820-2
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!